Cargando…

Selegiline: a molecule with innovative potential

Monoamine oxidase B (MAO-B) inhibitors have an established role in the treatment of Parkinson’s disease as monotherapy or adjuvant to levodopa. Two major recognitions were required for their introduction into this therapeutic field. The first was the elucidation of the novel pharmacological properti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tábi, Tamás, Vécsei, László, Youdim, Moussa B., Riederer, Peter, Szökő, Éva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2019
Materias:	Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242272/ https://www.ncbi.nlm.nih.gov/pubmed/31562557 http://dx.doi.org/10.1007/s00702-019-02082-0

Ejemplares similares

Lack of insulin resistance in response to streptozotocin treatment in neuronal SH-SY5Y cell line
por: Bagaméry, Fruzsina, et al.
Publicado: (2019)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
por: Danysz, Wojciech, et al.
Publicado: (2021)

Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy
por: Fakan, Bernadett, et al.
Publicado: (2020)

L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023)

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
por: Riederer, Peter, et al.
Publicado: (2020)

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022)

Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
por: Riederer, P., et al.
Publicado: (2021)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023)

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
por: Wulf, Maximilian, et al.
Publicado: (2022)

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
por: Gschmack, Eva, et al.
Publicado: (2022)

Examination of betahistine bioavailability in combination with the monoamine oxidase B inhibitor, selegiline, in humans—a non-randomized, single-sequence, two-period titration, open label single-center phase 1 study (PK-BeST)
por: Strupp, Michael, et al.
Publicado: (2023)

The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis
por: Tóth, Eszter, et al.
Publicado: (2019)

Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance
por: Kocsis, Krisztián, et al.
Publicado: (2021)

Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
por: Kincses, Bálint, et al.
Publicado: (2019)

Altered Resting State Functional Activity and Microstructure of the White Matter in Migraine With Aura
por: Faragó, Péter, et al.
Publicado: (2019)

Are Migraine With and Without Aura Really Different Entities?
por: Kincses, Zsigmond Tamás, et al.
Publicado: (2019)

The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease
por: Giorgi, Filippo Sean, et al.
Publicado: (2021)

Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice
por: Szepesy, Judit, et al.
Publicado: (2021)

Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene
por: Zádori, Dénes, et al.
Publicado: (2020)

VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease
por: Eleuteri, Simona, et al.
Publicado: (2019)

A brief history of brain iron accumulation in Parkinson disease and related disorders
por: Foley, Paul B., et al.
Publicado: (2022)

Corrigendum: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
por: Nagy-Grócz, Gábor, et al.
Publicado: (2020)

Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations
por: Regensburger, Martin, et al.
Publicado: (2023)

Why do anti-inflammatory signals of bone marrow-derived stromal cells improve neurodegenerative conditions where anti-inflammatory drugs fail?
por: de Munter, J. P. J. M., et al.
Publicado: (2020)

Parkinson’s: a syndrome rather than a disease?
por: Titova, Nataliya, et al.
Publicado: (2016)

Editorial: Innovative models of stroke pathology
por: Crilly, Siobhan, et al.
Publicado: (2023)

A historical review of multiple system atrophy with a critical appraisal of cellular and animal models
por: Marmion, David J., et al.
Publicado: (2021)

Glutamate as a neurotransmitter in the healthy brain
por: Zhou, Y., et al.
Publicado: (2014)

Neurorehabilitation in dystonia: a holistic perspective
por: Bradnam, Lynley V., et al.
Publicado: (2020)

Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
por: Cova, Ilaria, et al.
Publicado: (2018)

Wilful pathogens provoke a gut feeling in Parkinson’s disease
por: Sian-Hülsmann, Jeswinder
Publicado: (2021)

A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease
por: Jost, Wolfgang H.
Publicado: (2022)

The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder
por: Jellinger, Kurt A.
Publicado: (2023)

From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview
por: Rausch, Wolf-Dieter, et al.
Publicado: (2022)

Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis
por: Heim, Beatrice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_usjii8j6uh45db4gjvo3q63gef